Testing Pembrolizumab Versus Observation in Patients With Merkel Cell Carcinoma After Surgery, STAMP Trial

NCT03712605 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

280

Enrollment

NIH

Sponsor class

Conditions

Pathologic Stage I Cutaneous Merkel Cell Carcinoma AJCC v8
Pathologic Stage II Cutaneous Merkel Cell Carcinoma AJCC v8
Pathologic Stage III Cutaneous Merkel Cell Carcinoma AJCC v8

Interventions

OTHER: Best Practice
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
PROCEDURE: Magnetic Resonance Imaging
BIOLOGICAL: Pembrolizumab
PROCEDURE: Positron Emission Tomography
RADIATION: Radiation Therapy

Sponsor

National Cancer Institute (NCI)